SciSparc Ltd. Ordinary Shares (SPRC) Dividend History

SciSparc Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) disorders. The company specializes in leveraging proprietary formulations of cannabinoids and other compounds to address conditions such as schizophrenia, autism spectrum disorder, and other neurological and psychiatric conditions. SciSparc aims to advance innovative therapies through research and clinical trials to improve patient outcomes in CNS health.

Website: https://www.scisparc.com

Dividend History

SciSparc Ltd. Ordinary Shares currently does not pay dividends

Company News

Autism Spectrum Disorder Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 20+ Companies and 22+ Therapies | DelveInsight

A comprehensive report reveals a robust pipeline for Autism Spectrum Disorder (ASD) treatments, with over 20 companies developing 22+ potential therapies, driven by improved diagnostics and increasing public awareness.

GlobeNewswire Inc.
SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

AutoMax, a leading automotive importer in Israel, received its first shipment of vehicles from JAC Motors, a Chinese automotive company. This marks a significant milestone for AutoMax's direct import and distribution operations, which were facilitated by financial support from SciSparc, a pharmaceutical company that has a merger agreement with AutoMax.

Benzinga
Dealing With Penny Stocks’ Short Term Price Movements

Use these tips to handle short term penny stocks price movements The post Dealing With Penny Stocks’ Short Term Price Movements appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: AVTX

Page data last updated 07/23/2025 14:39:19 UTC